Recursion Stock Jumps Before Goldman Sachs Event as AI-Drug Trade Gets Fresh Heat
Recursion shares surged about 12% to $3.87 on heavy volume ahead of its June 9 Goldman Sachs healthcare conference appearance, as investors look for updates on clinical timing, cash runway, and partnerships; small insider-sale filings were disclosed, and the move comes amid a broader rally in healthcare and AI drug-discovery stocks.